Welcome to our dedicated page for ACME UNITED SEC filings (Ticker: ACU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Acme United Corporation filings document the formal disclosures of an operating company that supplies first aid and medical products, safety solutions and cutting technology. Its 8-K reports include operating and financial results, material-event disclosures, acquisition-related reporting, credit-facility matters and other corporate updates affecting the company's capital and operating structure.
ACU proxy and annual-meeting filings cover board elections, executive compensation votes, equity incentive plan amendments and auditor ratification. The company's regulatory record also includes material agreement disclosures, including amendments to its secured revolving credit facility, along with governance matters and shareholder voting results.
ACME UNITED CORP director Holden Richmond Y Jr reported option-related transactions on 2026-07-24. He exercised employee stock options covering 1,500 shares at $21.20 and 1,900 shares at $21.75, receiving equivalent common stock. To cover the exercise price or tax obligations on a net share settlement basis, 606 and 788 common shares were withheld at $52.45 per share. The filing shows option exercises with associated share dispositions rather than open-market purchases or sales.
Acme United Corporation reported strong second quarter 2026 results, with net sales of $62.7 million, up 16% from a year earlier, and net income of $5.1 million, up 6%. Diluted EPS was $1.22 and gross margin improved to 42.6% from 41.0%.
For the first six months of 2026, net sales rose to $115.0 million, up 15%, while net income was $6.0 million and diluted EPS $1.46, both below the prior year, reflecting a 6% decline in net income and 7% decline in diluted earnings per share caused primarily by first quarter results. The My Medic acquisition and a German cutting and sharpening product line contributed to growth.
U.S. segment sales grew 17% in the quarter, Europe rose 24% in U.S. dollars, and Canada increased 1%. Bank debt less cash was $27.3 million, and the company entered into a new $65 million syndicated credit facility maturing July 15, 2029 to replace its prior facility. Management noted that high tariffs will continue to pressure margins, but at a decreasing rate, and expects My Medic profitability to remain weighted to the fourth quarter.
Acme United Corporation entered into a new $65 million syndicated credit facility with HSBC Bank USA, National Association, and City National Bank, replacing its prior $65 million facility with HSBC. The facility is intended to provide liquidity for growth, acquisitions, dividends, and other business activities and expires on July 15, 2029.
Borrowings bear interest at Term SOFR plus an applicable margin of 2.00%–2.75%, based on the company’s Net Funded Debt to EBITDA ratio, with a 0.25% per annum commitment fee on unused commitments. The facility is secured by a first-priority lien on substantially all company assets and includes quarterly covenants capping Net Funded Debt to EBITDA at 3.75 to 1.00 and requiring a minimum Fixed Charge Coverage Ratio of 1.10 to 1.00. On July 15, 2026, the opening balance was $28.5 million, equal to the payoff of the former credit facility.
ACME UNITED CORP director and CEO Walter C. Johnsen reported a bona fide gift of 5,834 shares of Common Stock on May 27, 2026. The shares were transferred at a reference price of $42.23 per share. After the gift, he directly holds 314,999 Common Stock shares.
ACME UNITED CORP director and President/COO Brian S. OlschAN reported an open-market sale of company stock. On May 28, 2026, he sold 4,833 shares of ACME UNITED CORP common stock at a price of $42.00 per share.
Following this transaction, he directly holds 41,172 shares of common stock. The filing reports no associated derivative security exercises, conversions, or tax-withholding transactions.
ACME United Corp. reported an insider sale notice: 15,000 shares were listed for sale by Brian Olschan. The filing shows $688,200.00 tied to the reported transaction date 02/27/2026. The notice also lists stock awards dated 06/17/2025 (37 shares) and 05/22/2026 (4,796 shares).
ACME United Corp President and COO Brian Olschan exercised employee stock options for 20,000 shares of Common Stock at $24.92 per share. To cover tax obligations, 15,204 shares were disposed of at $43.21 per share through share withholding, not an open-market sale. After these transactions, he directly holds 46,005 Common shares and 241,700 employee stock options.
ACME UNITED CORP director and CEO Walter C. Johnsen exercised stock options and had shares withheld for taxes. He exercised 30,000 Employee Stock Options at $23.99 per share, converting them into Common Stock in a routine compensation-related move.
To cover tax obligations, 24,166 Common Stock shares were disposed of at $40.53 per share through a tax-withholding transaction, not an open-market sale. After these transactions, Johnsen directly owns 320,833 Common Stock shares.
Acme United’s first quarter 2026 showed higher sales but lower profit. Net sales rose to $52.3 million, up 14% from a year earlier, helped by stronger first aid and medical demand and the January acquisition of My Medic. Excluding My Medic, comparable sales grew 6%.
Net income fell to $1.0 million from $1.7 million as higher tariffs, quality investments and personnel costs pushed selling and administrative expenses up to $19.0 million. Diluted EPS declined to $0.24 from $0.41. Operating cash flow was a use of $2.2 million, mainly from higher receivables and inventory.
The company bought My Medic for $18.6 million (including contingent and holdback amounts); the business added $3.4 million in revenue. To fund the deal and working capital, borrowings under the revolving credit facility increased to $33.0 million, raising the long‑term debt to equity ratio to 36.3%. Management says it remains in covenant compliance and views existing cash and credit capacity as sufficient for the next twelve months.
ACME United Corporation reported the results of its 2026 Annual Meeting of Shareholders held on April 27, 2026. Shareholders elected all seven director nominees, each receiving over 2.82 million votes for, with relatively few votes withheld.
Investors approved an amendment to the 2022 Employee Stock Option Plan with 1,951,474 votes for and 925,794 against, and supported a non-binding advisory resolution on named executive officer compensation with 2,775,611 votes for and 102,051 against. Shareholders also ratified the appointment of CBIZ CPA's, P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 3,413,803 votes in favor.